ResourcesHeadlineDark Gray3.00000000000000Resources
Arizona's Biomedical HubHTML ContentNavy1.00000000000000Arizona's Biomedical Hub<div class="ExternalClass51D6FFB5BED8403D9B702D5D61945ACA"><html> <div class="ExternalClass5F504BE0FE1A46E7A6C274CE3EB32A85"> <span style="font-size:17.3333px;">As the 5th largest city in the nation, Phoenix boasts institutes of excellence in precision medicine, genomics, molecular medicine, cancer research, healthcare analytics, medical education, and others. Nowhere is this more concentrated than on the Phoenix Biomedical Campus, 30-acres at the center of Phoenix’s innovator’s core, the PHX Core, in Downtown Phoenix. </span></div><div class="ExternalClass5F504BE0FE1A46E7A6C274CE3EB32A85"><span style="font-size:17.3333px;"><br>Join the frontier of personalized medicine in Phoenix. Unprecedented collaboration between innovators and institutions of excellence sets a new standard. This is the city in which ideas are nurtured, innovation is celebr​ated, and n​ew explorers are welcome.  </span></div><div class="ExternalClass5F504BE0FE1A46E7A6C274CE3EB32A85"><p><span style="font-size:17.3333px;">​</span></p><p style="text-align:center;"><span style="font-size:17.3333px;">​<a href="/Documents/Phoenix%20Biomedical%20Campus%202020.pdf" target="_blank"><span style="background-color:rgb(242, 242, 242);">Phoenix Biomedical Campus Brochure Download</span></a><span style="background-color:rgb(242, 242, 242);">​</span></span></p></div></html></div>1
Explore the PossibilitiesVideoLight Gray2.00000000000000Explore the Possibilities<div class="ExternalClass026728C8E0B94CC0AFE4893D42958BAC"><html> <p> <span id="ms-rterangepaste-start" aria-hidden="true"></span><span id="ms-rterangepaste-start"></span><a target="_blank" href="https://www.youtube.com/watch?v=i5a6yYRY1zc">https://www.youtube.com/watch?v=i5a6yYRY1zc</a>​<span id="ms-rterangepaste-end"></span></p> </html></div>

 

 

About the City of PhoenixAbout the City of Phoenix1.00000000000000https://www.phoenix.gov/econdevPencilIcons
Let the City of Phoenix Assist YouLet the City of Phoenix Assist You2.00000000000000https://www.phoenix.gov/econdev/bioHandIcons
Workforce AvailabilityWorkforce Availability3.00000000000000http://www.arizonaatwork.com/phoenix/Bar GraphIcons

 

 

EXACT SCIENCES LICENSES TARGETED DIGITAL SEQUENCING METHOD TO EXTEND LEADERSHIP IN PRECISION ONCOLOGYEXACT SCIENCES LICENSES TARGETED DIGITAL SEQUENCING METHOD TO EXTEND LEADERSHIP IN PRECISION ONCOLOGY<div class="ExternalClassBC85741865824F7DA0A12B1185AD30A1"><html> <p>​<span style="font-style:italic;color:rgb(85, 85, 85);font-family:"helvetica neue", helvetica, arial, sans-serif;font-size:14px;background-color:window;box-sizing:border-box;border-radius:0px;">Written by</span><span style="font-style:italic;color:rgb(85, 85, 85);font-family:"helvetica neue", helvetica, arial, sans-serif;font-size:14px;background-color:window;"> </span><span class="uBlogsy_author_name" style="font-style:italic;color:rgb(85, 85, 85);font-family:"helvetica neue", helvetica, arial, sans-serif;font-size:14px;background-color:window;box-sizing:border-box;border-radius:0px;"><a target="_blank" href="https://www.tgen.org/news/?author=Steve+Yozwiak" title="Steve Yozwiak" style="box-sizing:border-box;border-radius:0px;background-color:transparent;color:rgb(85, 85, 85);outline:0px !important;">Steve Yozwiak</a></span></p> <div class="row" style="box-sizing:border-box;border-radius:0px;margin-right:-15px;margin-left:-15px;color:rgb(85, 85, 85);font-family:"helvetica neue", helvetica, arial, sans-serif;font-size:14px;"> <div class="col-md-12" style="box-sizing:border-box;border-radius:0px;min-height:1px;padding-right:15px;padding-left:15px;"> <ul class="list-inline posted-info" style="box-sizing:border-box;border-radius:0px;margin-top:0px;margin-bottom:10px;padding-left:0px;margin-left:-5px;list-style:none;"> <em style="background-color:window;box-sizing:border-box;border-radius:0px;">​Worldwide Exclusive License Provides Access to Targeted Digital Sequencing (TARDIS) Blood Biopsy Method for Use in Minimal Residual Disease Testing</em></ul> <br> </div> </div> <div class="row" style="box-sizing:border-box;border-radius:0px;margin-right:-15px;margin-left:-15px;color:rgb(85, 85, 85);font-family:"helvetica neue", helvetica, arial, sans-serif;font-size:14px;"> <div class="col-md-12" style="box-sizing:border-box;border-radius:0px;min-height:1px;padding-right:15px;padding-left:15px;"> <p style="box-sizing:border-box;border-radius:0px;margin:0px 0px 20px;"> <span style="box-sizing:border-box;border-radius:0px;font-weight:700;">MADISON, Wis. — January 13, 2021 —</span> <a target="_blank" href="https://www.exactsciences.com/" style="box-sizing:border-box;border-radius:0px;background-color:transparent;color:rgb(12, 72, 135);outline:0px !important;">Exact Sciences Corp.</a> (Nasdaq: EXAS) today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology from the <a target="_blank" href="https://www.tgen.org/" style="box-sizing:border-box;border-radius:0px;background-color:transparent;color:rgb(12, 72, 135);outline:0px !important;">Translational Genomics Research Institute (TGen)</a>, an affiliate of <a target="_blank" href="https://www.cityofhope.org/homepage" style="box-sizing:border-box;border-radius:0px;background-color:transparent;color:rgb(12, 72, 135);outline:0px !important;">City of Hope</a>. This compelling and technically distinct approach will help expand Exact Sciences’ leadership in precision oncology and offers a differentiated patient-specific solution in minimal residual disease testing.</p> <p style="box-sizing:border-box;border-radius:0px;margin:0px 0px 20px;">Analysis of DNA shed into a patient’s blood stream can provide a noninvasive means of detecting the presence of a tumor. Patients who have undergone initial treatment may only have small amounts of tumor DNA in their blood, which can be difficult to detect with conventional technology. TARDIS was developed to be highly sensitive and customizable for each patient, including those with only a trace amount of tumor remaining following surgery or other localized treatment that is undetectable by imaging.<span style="box-sizing:border-box;border-radius:0px;font-size:10.5px;line-height:0;vertical-align:baseline;top:-0.5em;">i</span> </p> <p style="box-sizing:border-box;border-radius:0px;margin:0px 0px 20px;">“Exact Sciences is uniquely positioned to lead cancer diagnostics with our broad foundation and the talented team that created Cologuard® and Oncotype DX®,” said Kevin Conroy, chairman and CEO of Exact Sciences. “We’re excited to work with TGen and City of hope to bring the incredible TARDIS technology to physicians and patients and deliver a better solution in minimal residual disease to improve cancer patient outcomes.”</p> <p style="box-sizing:border-box;border-radius:0px;margin:0px 0px 20px;">In a study published in <a target="_blank" href="https://stm.sciencemag.org/content/11/504/eaax7392" style="box-sizing:border-box;border-radius:0px;background-color:transparent;color:rgb(12, 72, 135);outline:0px !important;"><em style="box-sizing:border-box;border-radius:0px;">Science Translational Medicine</em></a>, TARDIS demonstrated high accuracy in assessing molecular response and residual disease during neoadjuvant therapy to treat breast cancer. TARDIS achieved up to 100-fold improvement beyond the current limit of circulating tumor DNA detection.<span style="box-sizing:border-box;border-radius:0px;font-size:10.5px;line-height:0;vertical-align:baseline;top:-0.5em;">i</span></p> <p style="box-sizing:border-box;border-radius:0px;margin:0px 0px 20px;">“Blood-based diagnostics are critical to the future of cancer care, and licensing TARDIS to an industry leader like Exact Sciences speaks volumes about its potential to positively impact the field,” said Jeffrey M. Trent, Ph.D., TGen president and research director. “The scale and reach Exact Sciences brings to the market means greater access — and new hope — for patients faced with a cancer diagnosis.”</p> <p style="box-sizing:border-box;border-radius:0px;margin:0px 0px 20px;">TGen became a part of City of Hope in 2016 to accelerate the speed at which scientists and medical staff convert research discoveries into cures for patients. City of Hope is a National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, making it a national leader in advancing research and treatment protocols.</p> <p style="box-sizing:border-box;border-radius:0px;margin:0px 0px 20px;">“We are proud of the innovation driven by TGen in the development of TARDIS technology and are excited about the licensing agreement with Exact Sciences as its leadership in screening and diagnostics combined with this novel approach will address a very important clinical challenge in cancer care,” said Robert Stone, president and CEO, City of Hope. “This is another example of City of Hope working with a leading organization around a joint vision to develop truly world-class solutions to transform the treatment of cancer patients.”</p> <p style="box-sizing:border-box;border-radius:0px;margin:0px 0px 20px;">XMS Capital is serving as financial advisor to Exact Sciences, and K&L Gates is serving as legal advisor. Citi is serving as financial advisor to TGen and City of Hope, and Jones Day is serving as legal advisor.<br style="box-sizing:border-box;border-radius:0px;"><br style="box-sizing:border-box;border-radius:0px;"></p> </div> </div> <p> <br> </p> </html></div>
​Event: CONNECT2STEM 2021 Returns as Dynamic Virtual Experience on Saturday January 30​​Event: CONNECT2STEM 2021 Returns as Dynamic Virtual Experience on Saturday January 30​<div class="ExternalClassCEA26E4021454F9380450CBD751FC062"><html> <p>The University of Arizona College of Medicine – Phoenix, along with partners, <a href="https://www.cox.com/residential/home.html" target="_blank">Cox Communications</a> and the Arizona SciTech Institute, present <strong>Connect2STEM 2021</strong> — a series of <strong>live virtual events</strong> starting January 30<sup>th</sup> at 10:00 AM MST showcasing the wonders of Science, Technology, Engineering, Math and Medicine (STEM). Connect2STEM is the signature kickoff event for Arizona's 10<sup>th</sup> annual statewide <a href="https://scitechinstitute.org/scitech-festival/" target="_blank">SciTech Festival</a>, a two-month campaign in February and March that promotes STEM events across the state. Attendees are encouraged to register for the virtual event at <a href="http://phoenixmed.arizona.edu/c2s" target="_blank">phoenixmed.arizona.edu/C2S</a> and those who register will automatically be entered to win an iPad. </p> <p>“The future will present new challenges that require inquisitive minds to solve," said Guy Reed, MD, MS, Dean of the UArizona College of Medicine – Phoenix. “Through Connect2STEM, we hope to inspire the next generation of creative thinkers, skilled innovators and compassionate leaders to pursue careers in STEM." </p> <p>“Arizona's future depends on a highly-trained workforce – particularly in the areas of advanced medical technology, research, and related STEM fields – and the SciTech Festival delivers on that vision," said Phoenix Mayor Kate Gallego. “I am particularly grateful to the University of Arizona and Phoenix Biomedical campus for organizing this year's event and for engaging young minds during this challenging time."</p> <p> </p> <p>Visit <a href="http://phoenixmed.arizona.edu/c2s" target="_blank"><strong>phoenixmed.arizona.edu/C2S</strong></a> to access the full schedule of live programs, printable fun sheets and access to new videos. ​<br></p> <span id="ms-rterangepaste-end"></span> <p> <br> <br> </p> </html></div>
Event: Open Invitation for Tours – For Lease: 850 N 5th Street Innovation Center by Wexford Science+TechnologyEvent: Open Invitation for Tours – For Lease: 850 N 5th Street Innovation Center by Wexford Science+Technology<div class="ExternalClass5423C1D4E40A4266B8AFB3D3245DE05F"><html>​​<span style="background-color:window;color:windowtext;font-family:inherit;font-size:10pt;">After years of visioning, planning, and construction, 850 N 5th Street is available for lease.​</span><span style="background-color:window;color:windowtext;font-family:inherit;font-size:10pt;" id="ms-rterangepaste-end"></span><span style="background-color:window;color:windowtext;font-family:inherit;font-size:10pt;">. The building is a collaborative effort between the City of Phoenix, Arizona State University, and Wexford Science & Technology, LLC. Totaling 227,000 SF with 100,000 SF of commercial lab or office space on the top three floors above Arizona State University research and innovation and GateWay Community College's Center for Entrepreneurial Innovation. 850 N 5th Street will be a gathering hub for life science and biomedical innovation. The building is part of ongoing expansion on the Phoenix Biomedical Campus, connecting the downtown biomedical campus to the Roosevelt Row Arts District. Designed to integrate research, entrepreneurial activity, and corporate engagement, 850 N 5th Street serves as a bridge between the surrounding neighborhoods, the academic community, and the professional community. The building's design purposefully invites the neighborhood to participate in its success through the first-floor program elements that are visually porous and accessible. A portion of the building will include turn-key lab space for private research, growing companies, or a soft-landing option for larger companies locating in Phoenix.</span><br><p> </p><p>To schedule a tour or receive information about available lease space please contact Kyle Jardine at <a target="_blank" href="mailto:%20Kyle.Jardine@wexfordscitech.com"><strong>Kyle.Jardine@wexfordscitech.com​</strong></a>  480.779.7181<br></p><p> <br> </p> </html></div>

© City of Phoenix Community and Economic Development